Get started
Work

SYS6010 combined with SYH2051 in advanced solid tumors: Results from a phase Ib/II trial.

Year: 2026
Type: conference-abstract
DOI: 10.1200/jco.2026.44.16_suppl.4044
Authors: Rongbo Lin, Liyu Su, Jiajing Chen, Rui-Hua Xu, Yan Zhang, Zuoxing Niu, Fei Yin, Yibing Liu, Zhiquan Qin, Zhiwei Li, Ying Liu, Ting Deng, Xiwen Huang, Jiansong Ji, Hui Yang, Huiyan Luo, Jinheng Hao, Ying Xin, Xuechao Wan, Lianchao Tian
Institutions: Fujian Provincial Cancer Hospital, Sun Yat-sen University Cancer Center, Shandong First Medical University, Shandong Tumor Hospital, Hebei Medical University, Fourth Hospital of Hebei Medical University, Henan Cancer Hospital, Zhejiang Provincial People's Hospital, Third Affiliated Hospital of Harbin Medical University, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Meizhou City People's Hospital, Lishui Central Hospital, Nanjing Medical University, CSPC Pharmaceutical Group
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7162569215
Cites:
Cited by:
Related to: